Description:

Phase II Consortium Phase II Lung Cancer - Advanced Disease Follow-Up Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF8E0C9E-44F2-3242-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF8E0C9E-44F2-3242-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 9/27/21
Uploaded on:

September 27, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Follow-Up - Phase II Lung Cancer - Advanced Disease Follow-Up Form - 2399268v1.0

Details

No Instruction available.

  1. StudyEvent: Phase II Lung Cancer - Advanced Disease Follow-Up Form
    1. No Instruction available.
Crf Header
Form Administration
Are data amended (If data are amended, please circle in red when using paper form)
Lung: Pre-treatment Characteristics
Patient's Vital Status
Primary Cause of Death
Lung: Disease Follow-up Status
Has the patient had a documented clinical assessment for this cancer? (since submission of the previous follow-up form)
Lung: Notice Of Progression/site
Has the patient developed a first progression (or relapse) that has not been previously reported?
Sites of progression (check all that apply)
7 more items in the detailed view.
Lung: Subsequent Non-protocol Therapy
Is the patient receiving any non-protocol cancer therapy not previously reported?
Non-Protocol Therapy Type (check all that apply)
4 more items in the detailed view.
Lung: Notice Of New Primary
Has a new primary cancer or MDS been diagnosed that has not been previously reported? (myelodysplastic syndrome)
Lung: Long-term Toxicity
Has the patient experienced (prior to diagnosis of recurrence or second primary) any severe (Grade >=3), long term toxicity that has not been previously reported
Comments
Back to the top of the page 

Similar models